Protein Science, Vol 3, Issue 5 822-830, Copyright © 1994 by Cold Spring Harbor Laboratory Press

ARTICLE

Conserved phosphorylation of serines in the Ser-X-Glu/Ser(P) sequences of the vitamin K-dependent matrix Gla protein from shark, lamb, rat, cow, and human

P. A. PRICE, J. S. RICE and M. K. WILLIAMSON
Department of Biology, University of California at San Diego, La Jolla, California 92093-0322

The present studies demonstrate that matrix Gla protein (MGP), a 10-kDa vitamin K-dependent protein, is phosphorylated at 3 serine residues near its N-terminus. Phosphoserine was identified at residues 3, 6, and 9 of bovine, human, rat, and lamb MGP by N-terminal protein sequencing. All 3 modified serines are in tandemly repeated Ser-X-Glu sequences. Two of the serines phosphorylated in shark MGP, residues 2 and 5, also have glutamate residues in the n + 2 position in tandemly repeated Ser-X-Glu sequences, whereas the third, shark residue 3, would acquire an acidic phosphoserine in the n + 2 position upon phosphorylation of serine 5. The recognition motif found for MGP phosphorylation, Ser-X-Glu/Ser(P), has been seen previously in milk caseins, salivary proteins, and a number of regulatory peptides. A review of the literature has revealed an intriguing dichotomy in the extent of serine phosphorylation among secreted proteins that are phosphorylated at Ser-X-Glu/Ser(P) sequences. Those phosphoproteins secreted into milk or saliva are fully phosphorylated at each target serine, whereas phosphoproteins secreted into the extracellular environment of cells are partially phosphorylated at target serine residues, as we show here for MGP and others have shown for regulatory peptides and the insulin-like growth factor binding protein 1. We propose that the extent of serine phosphorylation regulates the activity of proteins secreted into the extracellular environment of cells, and that partial phosphorylation can therefore be explained by the need to ensure that the phosphoprotein be poised to gain or lose activity with regulated changes in phosphorylation status. The presence of 3 phosphoserine residues in all MGPs tested, which span shark to man, strongly supports the conclusion that phosphorylation of 3 serine residues is critical to the as yet unknown function of MGP. We have previously speculated that MGP is a locally acting regulator of cell growth and/or differentiation in the wide variety of cells that secrete the protein. Evidence for this hypothesis includes the strong induction of MGP expression by retinoic acid, a potent morphogen, and the independent discovery of MGP by differential cDNA screening as a gene that is overexpressed in transformed cells, in cells undergoing apoptosis, and in cells undergoing differentiation changes in culture. If MGP indeed acts on target cells near the point of its secretion to achieve changes in growth and/or differentiation, then regulated changes in the extent of MGP phosphorylation could provide a rapid and sensitive mechanism for controlling its activity. In the course of these studies we have made 2 improvements in the use of ethanethiol derivatization to identify phosphoserine residues during N-terminal protein sequencing, the demonstration that this reaction can be carried out on proteins bound to a polyvinylidene difluoride membrane and the observation that maximal conversion of phosphoserine to S-ethylcysteine requires 4 h at 60{deg}C rather than the previously published 1 h at 50{deg}C.
CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. J. H. van Summeren, W. G. M. Spliet, A. van Royen-Kerkhof, C. Vermeer, M. Lilien, W. Kuis, and L. J. Schurgers Calcinosis in juvenile dermatomyositis: a possible role for the vitamin K-dependent protein matrix Gla protein Rheumatology, March 1, 2008; 47(3): 267 - 271. [Abstract] [Full Text] [PDF]

				S. Saito, K. Yano, S. Sharma, H. E. McMahon, and S. Shimasaki Characterization of the post-translational modification of recombinant human BMP-15 mature protein Protein Sci., February 1, 2008; 17(2): 362 - 370. [Abstract] [Full Text] [PDF]

				H. E. McMahon, S. Sharma, and S. Shimasaki Phosphorylation of Bone Morphogenetic Protein-15 and Growth and Differentiation Factor-9 Plays a Critical Role in Determining Agonistic or Antagonistic Functions Endocrinology, February 1, 2008; 149(2): 812 - 817. [Abstract] [Full Text] [PDF]

				C. J. O'Donnell, M. K. Shea, P. A. Price, D. R. Gagnon, P. W. F. Wilson, M. G. Larson, D. P. Kiel, U. Hoffmann, M. Ferencik, M. E. Clouse, et al. Matrix Gla Protein Is Associated With Risk Factors for Atherosclerosis but not With Coronary Artery Calcification Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2769 - 2774. [Abstract] [Full Text] [PDF]

				V. Laize, P. Martel, C. S. B. Viegas, P. A. Price, and M. L. Cancela Evolution of Matrix and Bone {gamma}-Carboxyglutamic Acid Proteins in Vertebrates J. Biol. Chem., July 22, 2005; 280(29): 26659 - 26668. [Abstract] [Full Text] [PDF]

				N. Wajih, T. Borras, W. Xue, S. M. Hutson, and R. Wallin Processing and Transport of Matrix {gamma}-Carboxyglutamic Acid Protein and Bone Morphogenetic Protein-2 in Cultured Human Vascular Smooth Muscle Cells: EVIDENCE FOR AN UPTAKE MECHANISM FOR SERUM FETUIN J. Biol. Chem., October 8, 2004; 279(41): 43052 - 43060. [Abstract] [Full Text] [PDF]

				K. Kawasaki, T. Suzuki, and K. M. Weiss Genetic basis for the evolution of vertebrate mineralized tissue PNAS, August 3, 2004; 101(31): 11356 - 11361. [Abstract] [Full Text] [PDF]

				P. A. Price, T. M. T. Nguyen, and M. K. Williamson Biochemical Characterization of the Serum Fetuin-Mineral Complex J. Biol. Chem., June 6, 2003; 278(24): 22153 - 22160. [Abstract] [Full Text] [PDF]

				P. A. Price, G. R. Thomas, A. W. Pardini, W. F. Figueira, J. M. Caputo, and M. K. Williamson Discovery of a High Molecular Weight Complex of Calcium, Phosphate, Fetuin, and Matrix gamma -Carboxyglutamic Acid Protein in the Serum of Etidronate-treated Rats J. Biol. Chem., February 1, 2002; 277(6): 3926 - 3934. [Abstract] [Full Text] [PDF]

				P. A. Price, S. A. Faus, and M. K. Williamson Warfarin-Induced Artery Calcification Is Accelerated by Growth and Vitamin D Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 317 - 327. [Abstract] [Full Text] [PDF]

				P. A. Price, S. A. Faus, and M. K. Williamson Warfarin Causes Rapid Calcification of the Elastic Lamellae in Rat Arteries and Heart Valves Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1400 - 1407. [Abstract] [Full Text] [PDF]

				B. Hu, L. Coulson, B. Moyer, and P. A. Price Isolation and Molecular Cloning of a Novel Bone Phosphoprotein Related in Sequence to the Cystatin Family of Thiol Protease Inhibitors J. Biol. Chem., January 6, 1995; 270(1): 431 - 436. [Abstract] [Full Text] [PDF]